Chimeric Antibody Receptor-Encoded Epitopes Elicit Immune Responses in Patients Treated with Engineered T-Cells
Adoptive transfer of immune effector cells that are gene modified by retroviral transducion to express tumor-specific receptors constitute an attractive approach to treat cancer. In patients with metastatic renal cell carcinoma (RCC), we performed a study with autologous T-cells genetically retarget...
Gespeichert in:
Veröffentlicht in: | Human gene therapy 2010-04, Vol.21 (4), p.501-501 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!